Home > Insider Trading > Filing (0001209191-21-007918)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1496323	Igm Biosciences Inc.	IGMS	Pharmaceutical Preparations (2834)	770349194

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1787681	Shinyu Daniel Chen	C/O Igm Biosciences, Inc. 325 E. Middlefield Road Mountain View CA 94043	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-02	1,900	$1.39	118,373	No	4	M	Direct
Common Stock	Disposition	2021-02-02	674	$96.40	117,699	No	4	F	Direct
Common Stock	Disposition	2021-02-03	1,226	$96.00	116,473	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-02-02	1,900	$0.00	1,900	$1.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
347,790		2028-12-30	No	4	M	Direct

Footnotes

The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
Represents shares withheld by the Issuer to pay the exercise price and taxes pursuant to the "net exercise" of 1,900 option shares.
The option, originally for 361,090 shares, of which 13,300 shares have been exercised, vested as to 1/4 of the shares on August 1, 2019, and an additional 1/48 of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person remaining a service provider through each such date.